Background and Aim: Western societies, with growing prevalence, suffer from various metabolic diseases like obesity and hepatic steatosis, better defined as non-alcoholic fatty liver disease, or cardiovascular (CV) diseases that are strictly linked to each other. The association of their occurrence with the altered homeostasis of metals is an intriguing issue. Copper in particular was identified as key player in various metabolic derangements. On these bases, we aimed at investigating the possible association of serum copper levels with an indicator of early CV risk as the intima-media thickness (IMT) of carotid artery and its predictive value in a selected population of obese patients. Methods: We performed a cross-sectional study recruiting 100 obese patients characterized by a low prevalence of comorbidities. Ultrasound investigation for hepatic steatosis and IMT evaluation were performed. Serum samples were collected and then analyzed through atomic absorption spectrometry to evaluate their copper content. Possible correlations between copper bioavailability and biochemical, clinical, and anthropometric characteristics of patients were sought. Results: Age negatively predicted copper serum levels of patients (P = 0.009). However, the most interesting finding is the negative prediction of IMT by the copper serum levels (t = À2.23, P = 0.028, least absolute deviations regression). Factor analysis confirmed the aforementioned inverse correlation and highlighted the strong inverse correlation between smoking and copper serum levels. Conclusion: Our data show that an altered copper bioavailability predicts early atherosclerosis as main CV risk in obese patients with hepatic steatosis detected by ultrasound, shedding some light in this pathological scenario.
Introduction
The wide changes in lifestyle and food habits occurred in the last decades, typically in the Western countries, caused a pronounced increase of metabolic derangements occurrence, such as obesity, type 2 diabetes mellitus (DM), hepatic steatosis (HS), that is, nonalcoholic fatty liver disease (NAFLD), and cardiovascular (CV) diseases, which are considered, to date, main global health burdens.
Of particular interest, even if too often understated, is the association of several metabolic derangements with the deregulation of biometal homeostasis. 1, 2 Aberrant biometal metabolism is a new key feature of CV disorders, including metabolic syndrome. In particular, copper is an essential trace element that plays key roles in many metabolic processes.
Dietary copper is absorbed in the stomach and in the upper intestinal tract and reaches liver as a complex with serum proteins, such as albumin, or amino acids. Liver is the major storehouse for copper that is, in turn, reduced in a cupric state and transported across plasma membrane by copper transporter 1 protein. This metal has a great redox potential because it is a main cofactor for several enzymatic reactions and participates in cellular metabolism, for example, aerobic respiration and antioxidant defense, ensuring the survival of living organisms. [3] [4] [5] Altered copper levels can promote oxidative stress occurrence and related dysfunctions, like inflammation onset. 6, 7 Accordingly, it is not surprising the very complex and redundant machinery that characterizes the control of copper, compared with other metals.
Homeostatic regulation of intracellular copper is normally tightly controlled, but deregulated copper levels are found in numerous metabolic diseases (e.g. NAFLD, obesity, diabetes, and dyslipidemia), characterized by an altered modulation of the subcellular biometal homeostasis. 1, 2, 8, 9 Reduced hepatic and serum copper levels, in fact, characterize NAFLD patients and seem to have a role in disease progression. 1 NAFLD, as well as obesity, 10 is deeply connected to CV diseases, which represents one of the main causes of NAFLD-related death.
wall as well as on atherosclerotic plaques 13, 14 and on platelet function. Both severe and marginal copper deficiency prompt aortic lesions in an experimental mouse model. 15 Furthermore, a reduced copper bioavailability can cause aortic lipid peroxidation and decrease of prostacyclin production, 16 which is crucial for vascular homeostasis and for the inhibition of platelet aggregation. On the other hand, it has been reported that copper serum levels are higher in atherosclerotic patients and are associated to disease severity. 17 Furthermore, it seems that copper accumulates in carotid lesions 14 and plays a key role in disease progression.
Because currently obese patients may be divided between metabolically healthy and metabolically unhealthy individuals by considering the presence of NAFLD, 18 we aimed at investigating, in a well-selected population of obese patients characterized by a low prevalence of comorbidities, if copper serum levels may support clinicians in predicting atherosclerotic risk. Thus, focusing on the carotid intima-media thickness (IMT), a non-invasive diagnostic tool for premature or subclinical atherosclerosis identification, as well as functional and structural marker of this process, 19 we highlighted, in our selected population of obese patients, the associations between copper status and IMT values.
Metal-modulating compounds might be promising therapeutics for preventing the CV risk related to different alterations of cellular metabolisms, but their mechanisms of action, till now, remain poorly understood.
Methods
This research was performed screening 100 consecutive subjects referred to our outpatient metabolic unit with established (at least 4 years) obesity, characterized by low prevalence of comorbidities, that is, type 2 DM or hypertension and without any serious CV event, recent or past, from November 2012 to November 2014. Few patients suffering from the aforementioned comorbidities were pharmacologically well compensated during recruitment.
The study was carried out according to the principles of the Declaration of Helsinki, and informed written consent was obtained from each patient.
Patients' enrollment. One hundred patients presenting ultrasound (US) finding of "bright liver" with or without hypertransaminasemia of unknown origin or increase in gammaglutamyl transferase (γ-GT) activity, strictly in absence of other acute or chronic liver disease, whose age was not advanced ( Metabolic profile. Overweight or the class of obesity (I, II, and III) was established on the basis of body mass index cut-off points of 25-29.9, 30-34.9, 35-39.9, and > 40 kg/m 2 , respectively. Visceral obesity was evaluated by measuring waist circumference (WC) at the midpoint between the lower border of the rib cage and the iliac crest. Metabolic syndrome (MS) was defined according to the revised Adults Treatment Panel III (2001), and three or more criteria were considered: plasma glucose concentration of at least 100 mg/dL, WC > 88 cm, serum high-density lipoprotein (HDL) concentration < 50 mg/dL for women and < 40 mg/dL for men, blood pressure of over 130/85 mmHg, and serum triglyceride (TG) concentration of over 150 mg/dL. Insulin resistance (IR) status was determined by the homeostatic metabolic assessment (HOMA), which was assessed by the formula: fasting insulin (μU/mL) × fasting glucose (mg/dL) 405. 20 As stringent measure of IR, a value of HOMA > 2 was introduced, according to the cut-off value of surrogate measures of IR for MS in non-diabetic adults. 21 Moreover, as the repeated HOMA measurements presented a high variability within person in obese patients, HOMA values were averaged on the basis of at least five determinations to avoid misclassification. Regarding TG values, only the data of examines of patients who had fasted a minimum of 9 h before the morning examination were included to avoid false increases, averaging the results of at least two determinations made on different days. To avoid the high intraindividual variability, the TG/HDL cholesterol ratio was evaluated, setting abnormal values to ≥ 1.65 (men) and ≥ 1.32 (women). 22 Low-density lipoprotein (LDL) was calculated by using the following formula: LDL = total cholesterol À HDL À (TGs 5). An index weighting hepatic insulin resistance (hIR), generated through stepwise linear regression, that is, 2.2607 + 0.427 × log HOMA according to Stein et al., 23 was computed. The atherogenic index of plasma (AIP) was calculated according to the following formula: AIP = log TG HDL. 24 Ultrasound evaluation. Ultrasound measurements were performed by two operators, using an EsaOte system. Spleen longitudinal diameter was chosen to evaluate spleen volume and was carried out by posterolateral scanning. Maximum length (the optically greatest overall longitudinal dimension obtained from one of the two poles) and craniocaudal length (the optically maximal transversal dimension intercepting one of the two poles) were measured; the resulting values were then averaged, because the two measurements do not always coincide. 21 The classification of "bright liver" or HS was based on the following scale of hyperechogenicity: 0 = absent, 1 = light, 2 = moderate, and 3 = severe, pointing out the difference between the densities of the liver and the right kidney. Technically, echo intensity can be influenced by many factors, particularly by gain intensity. To avoid confounding factors that could modify echo intensity and thus bias comparisons, the mean brightness levels of both the liver and the right kidney cortex were obtained on the same longitudinal sonographic plane. The levels of brightness of the liver and the right kidney were calculated three times directly from the frozen images.
Intima-media thickness evaluation. The common carotid artery, the carotid bulb, and the near and far wall segments of the internal carotid artery were scanned bilaterally. Images were obtained in longitudinal sections with a single lateral angle of insonation, optimizing the image for the far wall. IMT was defined as the distance between the US interfaces of the lumen-intima and media-adventitia. Six manual measurements were performed, with automatic border detection, at equal distances along 1 cm on the far wall of the common carotid, according to the consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, endorsed by the Society for Vascular Medicine. 25 Blood pressure measurements. Systolic/diastolic blood pressure was the average of three consecutive readings taken by the physician during the day, during the usual practice hours, after subjects rested for 5 min in the sitting position.
Laboratory data. Blood samples were drawn in fasting conditions, into a 9-mL serum tube. Samples were centrifuged for 10 min at relative centrifugal force of 850-1000, collected, aliquoted, and frozen at À20°C, until further analyses. Serum TGs, HDL, basal insulin, alanine aminotransferase (ALT), γ-GT, cholinesterase, fasting glucose, fasting insulin, fibrinogen, iron, transferrin, and ferritin were performed at the time of enrolment by in-house standard procedures. High-sensitivity C-reactive protein (CRP) values, determined by the ELISA test, with reference values between 0.3 and 8.6 mg/L in healthy men and between 0.2 and 9.1 mg/L in healthy women (BioCheck, Inc., Foster City, CA, USA).
Copper and ceruloplasmin evaluations. Serum levels of ceruloplasmin were measured using an enzyme immune assay (CP [Human] ELISA Kit, Abnova, Taipei, Taiwan). The resultant color reaction was read at 450 nm by a Thermo Scientific Multiskan FC reader (Waltham, MA, USA). Intra-assay and inter-assay coefficients of variation were 4.7% and 7.1%, respectively.
Serum copper concentrations were quantified using a PerkinElmer AAnalyst 800 atomic absorption spectrophotometer equipped with an autosampler (both from PerkinElmer, Beaconsfield, UK) after serum samples dilution with HNO 3 . Analyses of serum copper were verified with a certified standard (Chebios, Rome, Italy).
Serum copper and ceruloplasmin reference intervals were calculated on 20 healthy subjects by the parametric method.
Statistics. Data, derived from a normally distributed population, are given as mean plus SD. Variables not normally distributed are expressed as median (25-75 interquartile range). The difference in medians was assessed by the Mann-Whitney test. The two-way cross-tabulation was set by the Pearson's correlation coefficient. Spearman's coefficient of rank correlation (ρ) and the Pearson's coefficient (r) were employed to analyze the correlation between data, when appropriate. At univariate analysis, the linear regression analysis (least squares) was used evaluating the coefficient with its standard error, 95% confidence intervals (CIs), and the t (t-value). In suspicion of heteroscedasticity, that is, when there were subpopulations that have different variabilities from others in the homoscedastic model, and having detected the presence of few outliers, we analyzed the correlation between copper and IMT by the robust regression, using least absolute deviations regression.
The factor analysis was applied to detect the structure in the relationships among variables, selecting a subset of variables having the highest correlations with the principal component factors. The concordance correlation coefficient (ρ c ), which measures precision and accuracy, was adopted to evaluate the degree of pair observations at US.
See the Supporting Information for more details about the statistical tools used to analyze our collection of data.
Results
General features. The number of individuals affected by different grades of obesity as well of severity of HS in our population was evidenced in Table 1 . Eighty-nine patients (89%) showed obesity between the second and third classes; the severity of obesity was well stratified for gender, not having detected any significant difference P = 0.5, Pearson's correlation coefficient. The major part of obese patients, 69 cases (69%), showed an HS of moderate grade. The moderate grade of HS was found in the highest degree of obesity, that is, class III with 43 cases with respect to 22 cases in class II of obesity and only four cases in class I of obesity (P = 0.0004, Pearson's correlation coefficient). Hypertension was detected using an appropriate cuff size and was not a perspicuous trait of our patients, being present in few cases (n = 4).
Sixteen patients suffered from type 2 DM, no one with hypertension. IR, evaluated as HOMA index, was significantly higher in subjects diagnosed with moderate grade of HS in confront to the light grade of HS (2.65 vs 1.42, P = 0.006, and Mann-Whitney U-test). ALT and γ-GT activity values in our patients were normal or slightly increased, indicating no particularly evident liver cytolysis.
The hIR value in men was significantly lower than systemic IR value, expressed as HOMA, that is, 2.48 versus 3.49, P = 0.003, and Mann-Whitney U-test; meanwhile in women, there was no difference, that is, hIR value 2.39 versus HOMA value 2.02, P = 0.45, and Mann-Whitney U-test. The increased presence of MS correlated with the increase the ALT and γ-GT serum levels (Spearman's ρ, P = 0.001). Serum copper reference interval was set as lower limit to μg/dL 75.3 (90% CI 66.88-83.72) and upper limit to μg/dL 159.8 (90% CI 149.7-169.8). Serum ceruloplasmin reference interval was set as lower limit mg/dL 23.9 (90% CI 21.1-26.8) and upper limit mg/dL 41.1 (90% CI 38.3-43.9), using normal distribution. Age-related intervals of serum ceruloplasmin and copper are shown in Figure 1 .
Serum copper bioavailability. The median value of serum copper, in our selected obese population, was not different when compared with that of the healthy subjects, selected for setting reference values, that is, μg/dL 99.7 (79.5-113) versus μg/dL 100.1 (91.9-110.75), P = 0.59 two-tailed probability, and Mann-Whitney U-test. Vice versa, the median value of serum ceruloplasmin of the obese was significantly higher with respect to that of the previously mentioned healthy subjects, that is, mg/dL 60.3 (47.3-78.3) versus mg/dL 33.8 (291.4-35.8), P = 0.0001 two-tailed probability, and Mann-Whitney U-test. Prediction (core finding) and other correlations. The most interesting finding is the negative prediction of IMT by the serum copper levels (coefficient À195.27, standard error 87.69, standard coefficient À0.219, tolerance 1.000, t = À2.23, P = 0.028, and robust regression: least absolute deviations regression) (Fig. 2) . In our selected obese population, an inverse correlation between the serum concentrations of copper and age was found, that is, ρ = À0.26, P = 0.012.
Triglycerides/HDL ratio well correlated with WC of the obese (ρ = 0.325, P = 0.007). γ-GT activity was associated with HOMA values (ρ = 0.50, P = 0.0001) as well as was with serum ferritin (ρ = 0.48, P = 0.001). The copper concentrations were related to CRP values (ρ = 0.21, P = 0.03) but not to fibrinogen serum levels (ρ = 0.08, P = 0.44). A no significant correlation was found between copper, ceruloplasmin levels, and spleen size, determined as spleen longitudinal diameter (ρ = 0.055, P = 0.61, and similarly, ρ = 0.055, P = 0.61).
At univariate analysis, that is, linear regression, copper levels were negatively predicted by age, with coefficient À0.51, standard error 0.19, 95% CI À0.89 to À0.13, t = À2.67, and P = 0.009.
At the factor analysis, studying the hidden relationships present in our population, we highlighted that (i) serum cholesterol, TGs, ferritin concentrations, and liver enzymes activity were strictly linked among themselves (factor 1); (ii) adiposity distribution, both evaluated as anthropometric measures and US features, was strongly associated with CRP (factor 2); and (iii) IMT was positively related to smoking and negatively to copper concentrations (factor 3), as evidenced in Table 2 .
Reliability. The intra-observational and inter-observational reproducibility of the sonographic estimations for bright liver was high, with a ρ c of 0.93 and 0.89, respectively.
Discussion
Obesity and NAFLD are metabolic diseases significantly associated with a great risk factor for CV diseases occurrence. 10 Accordingly, NAFLD is strictly linked to atherosclerosis and vascular diseases, 11 and coronary artery disease represents one of the main causes of death associated to NAFLD.
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This cross-sectional study was implanted to provide new knowledge on IMT value, as parameter of CV risk, in relation to copper serum levels. We were not planning to assess the prevalence of copper bioavailability alteration and/or of the onset of atherosclerosis in our selected population of obese patients with a low prevalence of comorbidities. The main finding presented here is the inverse relationship between serum copper and IMT value in obese patients with HS at US. Our data indicate the detrimental impact of reduced copper bioavailability on CV risk in a selected population of obese patients, because IMT of carotid artery is a renowned indicator of subclinical atherosclerosis as well as a prognostic parameter for CV risk evaluation. 26 Despite it was reported that copper may play a key role in NAFLD pathogenesis, because patients are characterized by low hepatic and serum copper levels, 1 there are no clinically proven diagnostic parameters based on biometal serum concentrations for predicting which overweight or obese patients will develop vascular damage. On these bases, the inverse correlation between IMT and copper serum concentration has to be taken into account and could shed a glimmer of light on the potential role of copper evaluation to detect subjects at increased risk for developing CV diseases.
The reasons underlying the impact of a reduced copper bioavailability on CV system need to be elucidated.
In our opinion, one possible explanation could be the consequent reduced activity of lysyl oxidase (LOX), a copper-dependent enzyme that is crucial for the cross-linking between collagen and elastin. 27 LOX is crucial to preserve endothelial function. Accordingly, LOX downregulation plays a key role in early atherosclerosis and endothelial dysfunctions. 28, 29 Furthermore, it was reported that in obese patients, the activity of LOX is reduced, and it is associated to an increased aortic stiffness. 27 Another possibility could be the serum levels of the blue protein ceruloplasmin. Ceruloplasmin is a protein with a wide variety of activities; it is known as an acute phase reactant 30 with potential protective roles. 31, 32 Increased ceruloplasmin serum levels were found significantly associated to the obesity, 33 but, to date, its real clinical significance is not known. 34 According to published data, we also observed elevated serum levels of ceruloplasmin. This protein is an enzyme synthesized in the liver, containing six atoms of copper in its structure, which carries more than 95% of the total copper in healthy human plasma. Ceruloplasmin shows on its protein surface some motifs able to loosely bind copper ions. 30 When ceruloplasmin levels are high, it can promote a high exchange of loosely bound copper into the endothelial cells leading to ROS generation and, in turn, deranging various intracellular pathways, like that of endothelial nitric oxide synthase. 35 Interestingly, endothelial nitric oxide synthase is a chief factor involved in the regulation of the vascular tone and the blood flow.
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It is noteworthy the fact that factor analysis did not highlighted any statistical correlation between iron and IMT, reinforcing our finding on the key and specific role of copper bioavailability in predicting early CV risk in our population of obese patients.
To further support the weight of our findings, the factor analysis has highlighted that the reduced serum copper levels have a similar statistical importance in IMT prediction to that of cigarette smoke, one of the main renowned risk factors for CV disease. 37, 38 On the other hand, the inverse correlation between serum copper levels and the age of our patients should be understood. Currently, it is known that copper levels increase with aging in healthy subjects. 4, 39 A possible explanation could reside in the food habits of obese patients, who often tend to favor a diet rich in carbohydrates, fat, and proteins at the expense of fruit and vegetables. Accordingly, a diet rich in cholesterol and fructose promotes a copper bioavailability alteration. 40 Finally, we are aware of the limitations of the present study; firstly, the type of study did not allow us to draw conclusions on the direction of the association. In fact, the cross-sectional nature of this design does not fulfill the temporal criteria needed to study the natural history of atherosclerosis. Another possible drawback was the lack of adiposity evaluated by the more precise magnetic resonance imaging. Furthermore, the definitions of the carotid segments vary for each study. This is a problem, because, between some studies, the "same" segments do not even overlap, that is, common carotid artery, carotid bifurcation, and internal carotid artery. Consequently, the studies differ in terms of how the results were reported. Apart from the reproducibility of the IMT measurement procedures, a further source of heterogeneity has been found between NAFLD and carotid IMT. 41 A possible pitfall was the lack of artery wall biopsy and subsequent culture of endothelial cells to detect the possible copper deposition.
Finally, we did not perform the liver biopsy because of technical (necessity of repeated passages due to the amount of subcutaneous adipose tissue) and ethical issues (lack of hepatic cytolysis).
Conclusion
Our data in obese patients with HS at US shed light on the impact of an altered copper bioavailability in predicting early atherosclerosis, suggesting it as a new potential parameter to be considered in the future CV risk assessment.
